Patents by Inventor Rishi G. Vaswani

Rishi G. Vaswani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORMS, COMPOSITIONS CONTAINING SAME, AND METHODS OF THEIR USE
    Publication number: 20240158387
    Abstract: Disclosed are crystalline forms of the compound of formula (I): (I) Also disclosed are compositions containing the crystalline forms of the compound of formula (I) and methods of their use. The methods may be for treating cancer in a subject in need thereof, e.g., by administering to the subject an effective amount of the crystalline form disclosed herein or its composition.
    Type: Application
    Filed: March 9, 2022
    Publication date: May 16, 2024
    Inventors: Rishi G. VASWANI, Chong-Hui GU
  • COMPOUNDS AND USES THEREOF
    Publication number: 20240101550
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: September 27, 2023
    Publication date: March 28, 2024
    Inventors: Rishi G. VASWANI, David S. HUANG
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230416248
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: November 10, 2021
    Publication date: December 28, 2023
    Inventors: Kevin J. WILSON, Solymar NEGRETTI, Shawn E.R. SCHILLER, Rishi G. VASWANI, David S. HUANG, Johannes H. VOIGT
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230149414
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: January 29, 2021
    Publication date: May 18, 2023
    Inventors: Neville John ANTHONY, Rishi G. VASWANI, David Simon MILLAN, Shawn E.R. SCHILLER, Kevin J. WILSON
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230138480
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: October 13, 2022
    Publication date: May 4, 2023
    Inventors: Neville John ANTHONY, David Simon MILLAN, Rishi G. VASWANI, Shawn E.R. SCHILLER
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230129003
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: October 11, 2022
    Publication date: April 27, 2023
    Inventors: Rishi G. VASWANI, David S. HUANG
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230121497
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: January 29, 2021
    Publication date: April 20, 2023
    Inventors: Rishi G. VASWANI, David S. HUANG, Kevin J. WILSON, Shawn E.R. SCHILLER, Neville John ANTHONY
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230079819
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: January 29, 2020
    Publication date: March 16, 2023
    Inventors: Rishi G. VASWANI, Neville John ANTHONY, David Simon MILLAN, Shawn E.R. SCHILLER, Kevin J. WILSON, David S. HUANG
  • Compounds and uses thereof
    Patent number: 11497752
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: November 15, 2022
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Neville John Anthony, David Simon Millan, Rishi G. Vaswani, Shawn E. R. Schiller
  • Compounds and uses thereof
    Patent number: 11485732
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: November 1, 2022
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Rishi G. Vaswani, David S. Huang
  • COMPOUNDS AND USES THEREOF
    Publication number: 20220119378
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: January 29, 2020
    Publication date: April 21, 2022
    Inventors: Neville John ANTHONY, Rishi G. VASWANI, David Simon MILLAN, Shawn E.R. SCHILLER
  • COMPOUNDS AND USES THEREOF
    Publication number: 20220098190
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Application
    Filed: January 29, 2020
    Publication date: March 31, 2022
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON, Francois BRUCELLE, Rishi G. VASWANI
  • COMPOUNDS AND USES THEREOF
    Publication number: 20210230154
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: January 29, 2021
    Publication date: July 29, 2021
    Inventors: Rishi G. VASWANI, David S. HUANG
  • COMPOUNDS AND USES THEREOF
    Publication number: 20210038611
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: January 29, 2019
    Publication date: February 11, 2021
    Inventors: Neville John ANTHONY, David Simon MILLAN, Rishi G. VASWANI, Shawn E.R. SCHILLER
  • LSD1 inhibitors and uses thereof
    Patent number: 10526287
    Abstract: Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with LSD1. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with LSD1.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: January 7, 2020
    Assignee: Constellation Pharmaceuticals, Inc.
    Inventors: Brian K. Albrecht, James Edmund Audia, Alexandre Côté, Martin Duplessis, Victor S. Gehling, Jean-Christophe Harmange, Rishi G. Vaswani
  • Synthesis of inhibitors of EZH2
    Patent number: 10457640
    Abstract: Provided herein are synthetic methods for the preparation of EZH2 inhibitors.
    Type: Grant
    Filed: October 18, 2017
    Date of Patent: October 29, 2019
    Assignee: Constellation Pharmaceuticals, Inc.
    Inventors: Rishi G. Vaswani, Michael Charles Hewitt
  • SYNTHESIS OF INHIBITORS OF EZH2
    Publication number: 20190233375
    Abstract: Provided herein are synthetic methods for the preparation of EZH2 inhibitors.
    Type: Application
    Filed: October 18, 2017
    Publication date: August 1, 2019
    Inventors: Rishi G. Vaswani, Michael Charles Hewitt
  • Therapeutic compounds and uses thereof
    Patent number: 10301253
    Abstract: Provided herein are compounds of formula I: and salts thereof and compositions and uses thereof. The compounds are useful as inhibitors of LSD1. Also included are pharmaceutical compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various LSD1-mediated disorders.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: May 28, 2019
    Assignees: GENENTECH, INC., CONSTELLATION PHARMACEUTICALS, INC.
    Inventors: Brian K. Albrecht, James Edmund Audia, Alexandre Cote, Martin Duplessis, Victor S. Gehling, Andrew Charles Good, Jean-Christophe Harmange, Yves LeBlanc, Christopher G. Nasveschuk, Alexander M. Taylor, Rishi G. Vaswani
  • MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
    Publication number: 20190125737
    Abstract: Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
    Type: Application
    Filed: May 31, 2018
    Publication date: May 2, 2019
    Inventors: Brian K. Albrecht, James Edmund Audia, Andrew Cook, Les A. Dakin, Martin Duplessis, Victor S. Gehling, Jean-Christophe Harmange, Christopher G. Nasveschuk, Rishi G. Vaswani
  • Modulators of methyl modifying enzymes, compositions and uses thereof
    Patent number: RE47428
    Abstract: Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: June 11, 2019
    Assignee: Constellation Pharmaceuticals, Inc.
    Inventors: Brian K. Albrecht, James Edmund Audia, Les A. Dakin, Victor S. Gehling, Jean-Christophe Harmange, Christopher G. Nasveschuk, Rishi G. Vaswani